{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T17:52:36Z","timestamp":1790790756073,"version":"4.1.0"},"reference-count":37,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,11,23]],"date-time":"2023-11-23T00:00:00Z","timestamp":1700697600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Public Health"],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>\n                      Although pneumococcal conjugate vaccines (PCV) have been effective in reducing the burden of\n                      <jats:italic>Streptococcus pneumoniae<\/jats:italic>\n                      infections, there is a paucity of data on the relationship with antimicrobial resistance (AMR) trends in the Arabian Gulf region. This study was carried out to assess\n                      <jats:italic>S. pneumoniae<\/jats:italic>\n                      resistance trends in the United Arab Emirates (UAE) where PCV-13 vaccination was introduced in 2011.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Retrospective analysis of\n                      <jats:italic>S. pneumoniae<\/jats:italic>\n                      demographic and microbiological data collected as part of the national AMR surveillance program from 2010 to 2021 was carried out. A survey of reporting sites and hand searching of annual reports of local health authorities was carried out to identify data on\n                      <jats:italic>S. pneumoniae<\/jats:italic>\n                      serotypes as this is not included in the AMR surveillance database.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      From 2010 to 2021, 11,242 non-duplicate\n                      <jats:italic>S. pneumoniae<\/jats:italic>\n                      isolates were reported, increasing from 324 in 2010 to 1,115 in 2021. Factoring in annual increment in the number of surveillance sites, the number of isolates per site showed an upward trajectory from 2015 to 2018 and declined in 2020 with the onset of the pandemic. The majority of isolates (\n                      <jats:italic>n\/N<\/jats:italic>\n                      = 5,751\/11,242; 51.2%) were from respiratory tract specimens with 44.5% (\n                      <jats:italic>n\/N<\/jats:italic>\n                      = 2,557\/5,751) being nasal colonizers. Up to 11.9% (\n                      <jats:italic>n\/N<\/jats:italic>\n                      = 1,337\/11,242) were invasive pneumococcal disease (IPD) isolates obtained from sterile site specimens including blood (\n                      <jats:italic>n<\/jats:italic>\n                      = 1,262), cerebrospinal (\n                      <jats:italic>n<\/jats:italic>\n                      = 52), pleural (\n                      <jats:italic>n<\/jats:italic>\n                      = 19) and joint (\n                      <jats:italic>n<\/jats:italic>\n                      = 4) fluid; and were predominantly from pediatric patients. The downward trend for amoxicillin and for penicillin G at the non-meningitis and meningitis as well as oral penicillin breakpoints was statistically significant. In contrast, increasing trends of resistance were seen for levofloxacin, moxifloxacin, trimethoprim\/sulfamethoxazole and erythromycin. IPD and non-IPD isolates showed similar demographic and AMR trends. None of the surveillance sites carried out\n                      <jats:italic>S. pneumoniae<\/jats:italic>\n                      serotyping and handsearching of annual reports did not yield this information.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      The increasing trend of pneumococcal disease and AMR with emergence of isolates with MDR phenotype despite is of concern. In the absence of\n                      <jats:italic>S. pneumoniae<\/jats:italic>\n                      serotyping the role of non-vaccine serotypes in driving this pattern remains unknown. There is an urgent need for serotype, genomic and AMR surveillance of\n                      <jats:italic>S. pneumoniae<\/jats:italic>\n                      isolates in the UAE.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fpubh.2023.1244357","type":"journal-article","created":{"date-parts":[[2023,11,23]],"date-time":"2023-11-23T07:10:25Z","timestamp":1700723425000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":18,"title":["Antimicrobial resistance in Streptococcus pneumoniae: a retrospective analysis of emerging trends in the United Arab Emirates from 2010 to 2021"],"prefix":"10.3389","volume":"11","author":[{"given":"Abiola","family":"Senok","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Thomsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Najiba M.","family":"Abdulrazzaq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"The UAE AMR Surveillance Consortium","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Godfred Antony","family":"Menezes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carole","family":"Ayoub Moubareck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dean","family":"Everett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,11,23]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e744","DOI":"10.1016\/S2214-109X(18)30247-X","article-title":"Burden of streptococcus pneumoniae and haemophilus influenzae type b disease in children in the era of conjugate vaccines: global, regional, and national estimates for 2000-15","volume":"6","author":"Wahl","year":"2018","journal-title":"Lancet Glob Health."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1016\/S1473-3099(18)30310-4","article-title":"Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory infections in 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016","volume":"18","author":"Collaborators","year":"2018","journal-title":"Lancet Infect Dis."},{"key":"B3","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1128\/mBio.00937-20","article-title":"A new pneumococcal capsule type, 10D, is the 100th serotype and has a large cps fragment from an oral streptococcus","author":"Ganaie","year":"2020","journal-title":"MBio"},{"key":"B4","doi-asserted-by":"publisher","first-page":"105085","DOI":"10.1016\/j.jbc.2023.105085","article-title":"Novel pneumococcal capsule type 33E results from the inactivation of glycosyltransferase WciE in vaccine type 33F","volume":"299","author":"Ganaie","year":"2023","journal-title":"J Biol Chem."},{"key":"B5","doi-asserted-by":"publisher","first-page":"12288","DOI":"10.1073\/pnas.1402981111","article-title":"Vaccines, new opportunities for a new society","volume":"111","author":"Rappuoli","year":"2014","journal-title":"Proc Natl Acad Sci U S A."},{"key":"B6","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.ijantimicag.2008.01.021","article-title":"Pneumococcal vaccines: mechanism of action, impact on epidemiology and adaption of the species","volume":"32","author":"Pletz","year":"2008","journal-title":"Int J Antimicrob Agents."},{"key":"B7","doi-asserted-by":"publisher","first-page":"F1000","DOI":"10.12688\/f1000research.22341.1","article-title":"Recent advances in the epidemiology and prevention of streptococcus pneumoniae infections","volume":"9","author":"Feldman","year":"2020","journal-title":"F1000Res."},{"key":"B8","unstructured":"London: Review on Antimicrobial Resistance2014"},{"key":"B9","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/S1473-3099(19)30297-X","article-title":"Pneumococcal lineages associated with serotype replacement and antibiotic resistance in childhood invasive pneumococcal disease in the post-PCV13 era: an international whole-genome sequencing study","volume":"19","author":"Lo","year":"2019","journal-title":"Lancet Infect Dis."},{"key":"B10","doi-asserted-by":"publisher","first-page":"2222","DOI":"10.1038\/s41467-020-15786-9","article-title":"High residual carriage of vaccine-serotype streptococcus pneumoniae after introduction of pneumococcal conjugate vaccine in Malawi","volume":"11","author":"Swarthout","year":"2020","journal-title":"Nat Commun."},{"key":"B11","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/S1473-3099(04)00938-7","article-title":"Streptococcus pneumoniae colonisation: the key to pneumococcal disease","volume":"4","author":"Bogaert","year":"2004","journal-title":"Lancet Infect Dis."},{"key":"B12","doi-asserted-by":"publisher","first-page":"4594","DOI":"10.1016\/j.vaccine.2017.07.009","article-title":"Population genetic structure, antibiotic resistance, capsule switching and evolution of invasive pneumococci before conjugate vaccination in Malawi","volume":"35","author":"Chaguza","year":"2017","journal-title":"Vaccine."},{"key":"B13","doi-asserted-by":"publisher","first-page":"18551","DOI":"10.1038\/s41598-020-75565-w","article-title":"Genotyping of methicillin resistant staphylococcus aureus from the United Arab Emirates","volume":"10","author":"Senok","year":"2020","journal-title":"Sci Rep."},{"key":"B14","doi-asserted-by":"publisher","first-page":"e0131372","DOI":"10.1371\/journal.pone.0131372","article-title":"Characterization of carbapenem-resistant enterobacteriaceae with high rate of autochthonous transmission in the Arabian peninsula","volume":"10","author":"Sonnevend","year":"2015","journal-title":"PLoS ONE."},{"key":"B15","doi-asserted-by":"publisher","first-page":"i45","DOI":"10.1093\/jac\/dkw064","article-title":"Results from the survey of antibiotic resistance (SOAR) 2011-13 in the Gulf states","volume":"71","author":"Jamsheer","year":"2016","journal-title":"J Antimicrob Chemother."},{"key":"B16","doi-asserted-by":"publisher","first-page":"296","DOI":"10.3855\/jidc.367","article-title":"Antimicrobial resistance among streptococcus pneumoniae and haemophilus influenzae isolates in the United Arab Emirates: 2004-2006","volume":"1","author":"Senok","year":"2007","journal-title":"J Infect Dev Ctries."},{"key":"B17","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.jiph.2013.06.004","article-title":"Pneumococcal disease in the Arabian Gulf: recognizing the challenge and moving toward a solution","volume":"6","author":"Feldman","year":"2013","journal-title":"J Infect Public Health."},{"key":"B18","doi-asserted-by":"publisher","first-page":"13","DOI":"10.4081\/monaldi.2006.580","article-title":"Demographics and microbiological profile of pneumonia in United Arab Emirates","volume":"65","author":"Al-Muhairi","year":"2006","journal-title":"Monaldi Arch Chest Dis."},{"key":"B19","doi-asserted-by":"publisher","first-page":"356","DOI":"10.4103\/0256-4947.83214","article-title":"The burden of pneumococcal disease in children less than 5 years of age in Abu Dhabi, United Arab Emirates","volume":"31","author":"Howidi","year":"2011","journal-title":"Ann Saudi Med."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1247627","DOI":"10.3389\/fpubh.2023.124762","article-title":"Surveillance of Antimicrobial Resistance in the United Emirates: the early implementation phase","volume":"11","author":"Thomsen","year":"2023","journal-title":"Front. Public Health."},{"key":"B21","volume-title":"Performance Standards for Antimicrobial Susceptibility Testing, 24th Informational Supplement (M100-S24).","author":"Institute","year":""},{"key":"B22","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1080\/00031305.1998.10480550","article-title":"Approximate is better than \u201cexact\u201d for interval estimation of binomial proportions","volume":"52","author":"Agresti","year":"1998","journal-title":"Am Stat."},{"key":"B23","doi-asserted-by":"publisher","first-page":"124","DOI":"10.4103\/jgid.jgid_125_19","article-title":"Morbidity and mortality due to pneumococcal disease in children in ecuador from 2005 to 2015","volume":"12","author":"Jimbo-Sotomayor","year":"2020","journal-title":"J Glob Infect Dis."},{"key":"B24","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1016\/S0140-6736(09)61204-6","article-title":"Burden of disease caused by streptococcus pneumoniae in children younger than 5 years: global estimates","volume":"374","author":"O'Brien","year":"2009","journal-title":"Lancet."},{"key":"B25","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1590\/S1020-49892009000300011","article-title":"The burden of pneumococcal disease among Latin American and Caribbean children: review of the evidence","volume":"25","author":"Valenzuela","year":"2009","journal-title":"Rev Panam Salud Publica."},{"key":"B26","doi-asserted-by":"publisher","first-page":"722483","DOI":"10.3389\/fped.2021.722483","article-title":"COVID-19 pandemic impact on respiratory infectious diseases in primary care practice in children","volume":"9","author":"Kaur","year":"2021","journal-title":"Front Pediatr."},{"key":"B27","doi-asserted-by":"publisher","first-page":"e80","DOI":"10.1016\/j.jinf.2022.05.040","article-title":"Changes in streptococcus pneumoniae infection in children before and after the COVID-19 pandemic in Zhengzhou, China","volume":"85","author":"Li","year":"2022","journal-title":"J Infect."},{"key":"B28","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.jinf.2005.11.006","article-title":"The influence of age and gender on the population-based incidence of community-acquired pneumonia caused by different microbial pathogens","volume":"53","author":"Guti\u00e9rrez","year":"2006","journal-title":"J Infect."},{"key":"B29","doi-asserted-by":"publisher","first-page":"30481","DOI":"10.2807\/1560-7917.ES.2017.22.10.30481","article-title":"Sex differences in invasive pneumococcal disease and the impact of pneumococcal conjugate vaccination in the Netherlands, 2004 to 2015","volume":"22","author":"Wagenvoort","year":"2017","journal-title":"Euro Surveill"},{"key":"B30","doi-asserted-by":"publisher","first-page":"479","DOI":"10.3201\/eid0805.010235","article-title":"Nasopharyngeal carriage of streptococcus pneumoniae in healthy children: implications for the use of heptavalent pneumococcal conjugate vaccine","volume":"8","author":"Marchisio","year":"2002","journal-title":"Emerg Infect Dis."},{"key":"B31","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1186\/s12879-021-06302-5","article-title":"Nasopharyngeal carriage of streptococcus pneumoniae among healthy children in Kassena-Nankana districts of Northern Ghana","volume":"21","author":"Narwortey","year":"2021","journal-title":"BMC Infect Dis."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1080\/14760584.2016.1198698","article-title":"Serotype distribution and penicillin-non-susceptibility of Streptococcus pneumoniae causing invasive diseases in Kuwait: a 10-year study of impact of pneumococcal conjugate vaccines","volume":"15","author":"Mokaddas","year":"2016","journal-title":"Expert Rev Vaccines."},{"key":"B33","doi-asserted-by":"publisher","first-page":"G37","DOI":"10.1016\/j.vaccine.2012.10.061","article-title":"Impact of pneumococcal conjugate vaccines on burden of invasive pneumococcal disease and serotype distribution of streptococcus pneumoniae isolates: an overview from Kuwait","volume":"30","author":"Mokaddas","year":"2012","journal-title":"Vaccine."},{"key":"B34","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s12879-019-4754-0","article-title":"Changes in pneumococcal carriage prevalence and factors associated with carriage in Norwegian children, four years after introduction of PCV13","volume":"20","author":"L\u00f8vlie","year":"2020","journal-title":"BMC Infect Dis."},{"key":"B35","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.jiph.2010.02.003","article-title":"Antimicrobial resistance in clinical isolates of Streptococcus pneumoniae in a tertiary hospital in Kuwait, 1997-2007: implications for empiric therapy","volume":"3","author":"Johny","year":"2010","journal-title":"J Infect Public Health."},{"key":"B36","doi-asserted-by":"publisher","first-page":"i60","DOI":"10.1093\/jac\/dkaa084","article-title":"Results from the Survey Of Antibiotic Resistance (SOAR) 2015-17 in the Middle East (Kuwait, Lebanon and Saudi Arabia): data based on CLSI, EUCAST (dose-specific) and pharmacokinetic\/pharmacodynamic (PK\/PD) breakpoints","volume":"75","author":"Torumkuney","year":"2020","journal-title":"J Antimicrob Chemother."},{"key":"B37","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1513\/AnnalsATS.201511-778FR","article-title":"Pneumococcal vaccination strategies. an update and perspective","volume":"13","author":"Berical","year":"2016","journal-title":"Ann Am Thorac Soc."}],"container-title":["Frontiers in Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2023.1244357\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,23]],"date-time":"2023-11-23T07:10:29Z","timestamp":1700723429000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2023.1244357\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,23]]},"references-count":37,"alternative-id":["10.3389\/fpubh.2023.1244357"],"URL":"https:\/\/doi.org\/10.3389\/fpubh.2023.1244357","relation":{},"ISSN":["2296-2565"],"issn-type":[{"value":"2296-2565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,23]]},"article-number":"1244357"}}